NCT03633474View on ClinicalTrials.gov

Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Meningitis, Bacterial
Interventions
BIOLOGICAL

N. lactamica

Stocks of N. lactamica (strain Y92-1009, sequence type 3493, clonal complex 613) in Frantz medium containing 30% (v/v) glycerol have been previously prepared using the Good Manufacturing Practices pharmaceutical manufacturing facilities at Public Health England (Porton Down, United Kingdom).

OTHER

PBS only

Sterile PBS only containing no bacteria

Trial Locations (1)

Unknown

NIHR Southampton Clinical Research Facility, Southampton

All Listed Sponsors
collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

lead

University of Southampton

OTHER

NCT03633474 - Defining the Immune Response to Nasopharyngeal Colonisation by the Commensal Neisseria Lactamica | Biotech Hunter | Biotech Hunter